TSE:OGI Organigram (OGI) Stock Price, News & Analysis → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free OGI Stock Alerts C$3.00 +0.20 (+7.14%) (As of 03/18/2024 ET) Add Compare Share Share Today's RangeC$2.78▼C$3.0650-Day RangeC$1.82▼C$3.0852-Week RangeC$1.35▼C$3.84Volume585,057 shsAverage Volume281,944 shsMarket CapitalizationC$282.30 millionP/E RatioN/ADividend YieldN/APrice TargetC$3.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines Get Organigram alerts: Email Address Organigram MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside26.7% UpsideC$3.80 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.22Based on 4 Articles This WeekInsider TradingSelling SharesC$62,965 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.81 out of 5 stars 3.3 Analyst's Opinion Consensus RatingOrganigram has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$3.80, Organigram has a forecasted upside of 26.7% from its current price of C$3.00.Amount of Analyst CoverageOrganigram has only been the subject of 3 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for OGI. Previous Next 0.0 Dividend Strength Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OGI. Previous Next 1.8 News and Social Media Coverage News SentimentOrganigram has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Organigram this week, compared to 1 article on an average week.Search InterestOnly 9 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$62,965.00 in company stock.Percentage Held by Insiders34.74% of the stock of Organigram is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 11.34% of the stock of Organigram is held by institutions. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioOrganigram has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy About Organigram Stock (TSE:OGI)Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.Read More OGI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OGI Stock News HeadlinesMarch 14, 2024 | insidertrades.comOrganigram Holdings Inc. (TSE:OGI) Director Donald Geoffrey Machum Sells 23,000 SharesMarch 16, 2024 | finance.yahoo.comOGI Apr 2024 1.500 putMarch 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.March 16, 2024 | americanbankingnews.comInsider Selling: Organigram Holdings Inc. (TSE:OGI) Director Sells C$62,964.80 in StockMarch 11, 2024 | theglobeandmail.comStrategic Investing with Eternity INC: A Guide to Building a Resilient PortfolioFebruary 28, 2024 | finance.yahoo.comOrganigram Applauds the Standing Committee on Finance’s Recommendation on Excise DutyFebruary 24, 2024 | fool.caThe Best Cannabis Stock to Buy Right NowFebruary 16, 2024 | finance.yahoo.comOGI Mar 2024 2.000 callMarch 19, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.February 15, 2024 | seekingalpha.comOrganigram Holdings Inc. (OGI) Q1 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comOrganiGram Holdings Inc. (NASDAQ:OGI) Q1 2024 Earnings Call TranscriptFebruary 13, 2024 | markets.businessinsider.comBuy Rating Affirmed for OrganiGram Holdings Amid Strong Profit Margins and Strategic Market PositioningFebruary 10, 2024 | ca.finance.yahoo.comOGI Sep 2024 2.000 putFebruary 10, 2024 | ca.finance.yahoo.comOGI Sep 2024 5.000 callJanuary 31, 2024 | finance.yahoo.comOrganigram Completes First Shipment to Germany, Extending its International ReachJanuary 24, 2024 | finance.yahoo.comOrganigram Announces the First Tranche Closing from BAT InvestmentJanuary 22, 2024 | theglobeandmail.comOrganiGram Holdings: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI)January 2, 2024 | seekingalpha.comWhy Organigram Is My Favorite Cannabis StockDecember 29, 2023 | finance.yahoo.comOrganigram Announces Mailing of Management Information Circular in Connection with Annual General and Special MeetingDecember 25, 2023 | markets.businessinsider.comJefferies Reaffirms Their Buy Rating on OrganiGram Holdings (OGI)December 21, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), OrganiGram Holdings (OGI) and Passage Bio (PASG)December 20, 2023 | seekingalpha.comOrganigram: Structural Issues In Canada RemainDecember 19, 2023 | finance.yahoo.comOrganiGram: Fiscal Q4 Earnings SnapshotNovember 28, 2023 | markets.businessinsider.comOrganigram: Phylos Achieves First Milestone Under Loan Agreement; Increases InvestmentNovember 28, 2023 | finance.yahoo.comOrganigram Increases Investment in Phylos After Successful Milestone AchievementNovember 10, 2023 | markets.businessinsider.comOrganigram Names Paolo De Luca Interim CFONovember 10, 2023 | finance.yahoo.comOrganigram Announces Interim Chief Financial OfficerSee More Headlines Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today3/18/2024Next Earnings (Estimated)4/09/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis Current SymbolTSE:OGI CUSIPN/A CIKN/A Webwww.organigram.ca Phone844-644-4726FaxN/AEmployees984Year FoundedN/APrice Target and Rating Average Stock Price TargetC$3.80 High Stock Price TargetC$6.50 Low Stock Price TargetC$2.25 Potential Upside/Downside+26.7%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($2.51) Trailing P/E RatioN/A Forward P/E Ratio33.48 P/E Growth0.42Net IncomeC$-229,480,000.00 Net Margins-153.80% Pretax MarginN/A Return on Equity-54.53% Return on Assets-5.56% Debt Debt-to-Equity Ratio1.75 Current Ratio6.95 Quick Ratio2.62 Sales & Book Value Annual SalesC$149.21 million Price / Sales1.89 Cash FlowC$0.78 per share Price / Cash Flow3.85 Book ValueC$3.18 per share Price / Book0.94Miscellaneous Outstanding Shares94,100,000Free FloatN/AMarket CapC$282.30 million OptionableNot Optionable Beta1.11 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMs. Beena G. Goldenberg (Age 60)CEO & Director Comp: $485.33kMs. Helen Martin (Age 46)Chief Legal Officer & Corporate Secretary Comp: $307.95kMr. Timothy EmbergChief Commercial OfficerMr. Paolo De Luca C.A. (Age 51)C.F.A, Chief Strategy Officer Comp: $306.7kMr. Greg Guyatt C.A.CPA, Chief Financial OfficerMs. Nathalie BattenSenior Vice President of OperationsMr. Geoff RiggsChief Information OfficerMax SchwartzDirector of Investor RelationsMs. Megan Amber McCraeSenior Vice President of Marketing & CommunicationsMs. Katrina May McFaddenChief People OfficerMore ExecutivesKey CompetitorsICC LabsCVE:ICCLeaf MobileTSE:LEAFCanopy GrowthTSE:WEEDESSA PharmaCVE:EPISupreme CannabisTSE:FIREView All CompetitorsInsidersDonald Geoffrey MachumSold 23,000 sharesTotal: C$62,964.80 ($2.74/share) OGI Stock Analysis - Frequently Asked Questions Should I buy or sell Organigram stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" OGI shares. View OGI analyst ratings or view top-rated stocks. What is Organigram's stock price target for 2024? 3 brokerages have issued 1 year price objectives for Organigram's shares. Their OGI share price targets range from C$2.25 to C$6.50. On average, they anticipate the company's stock price to reach C$3.80 in the next year. This suggests a possible upside of 26.7% from the stock's current price. View analysts price targets for OGI or view top-rated stocks among Wall Street analysts. How have OGI shares performed in 2024? Organigram's stock was trading at C$1.72 on January 1st, 2024. Since then, OGI shares have increased by 74.4% and is now trading at C$3.00. View the best growth stocks for 2024 here. When is Organigram's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 9th 2024. View our OGI earnings forecast. How were Organigram's earnings last quarter? Organigram Holdings Inc. (TSE:OGI) issued its earnings results on Tuesday, February, 13th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.13) by $0.06. The business had revenue of $36.46 million for the quarter, compared to the consensus estimate of $38.13 million. Organigram had a negative net margin of 153.80% and a negative trailing twelve-month return on equity of 54.53%. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACBFF), Green Organic Dutchman (TGOD), Charlotte's Web (CWBHF) and CannTrust (CTST). How do I buy shares of Organigram? Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:OGI) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.